Reviralofficially Known As Reviral Limitedis A Uk Based Biotechnology Company Focused On Developing Antiviral Therapiesfounded In 2011 And Headquartered In Sandwichkentreviral Is Dedicated To Research And Experimental Development In Biotechnologythe Company Has Successfully Raised $44 Million In Fundingindicating Strong Investor Interest In Its Innovative Approaches Reviral Specializes In Clinical Stage Antiviral Solutionsparticularly Targeting Viral Diseases Such As Respiratory Syncytial Virusrsv The Company Emphasizes Translational Researchwhich Connects Preclinical And Clinical Development To Bring Effective Therapies To Marketits Primary Stakeholders Include Healthcare Providerspharmaceutical Partnersand Investors Supporting Its Research And Development Efforts
